Logo-4

Molecular Targeting Technologies, Inc. and Molecular Theranostics Center of Singapore Receive HSA Approval for Clinical Trial Authorization for EBTATE® in Nasopharyngeal Cancer

WEST CHESTER, Pa. & SINGAPORE--(BUSINESS WIRE)--Molecular Targeting Technologies, Inc. (MTTI), and its wholly owned subsidiary, Molecular Theranostic Center of Singapore...

ANJIN_Gion_Shirakawa

Nazuna, a luxury Kyoto machiya lodging company, begins operation of “ANJIN Gion Shirakawa,” a one-house rental accommodation facility, limited to one guest per day

ANJIN Gion Shirakawa, a luxury renovated machiya house more than 115-year-old KYOTO, Japan--(BUSINESS WIRE)--Nazuna Co., Ltd., in partnership with JECT...